Advertisement

Catatonia in an Adolescent Girl with Inflammatory Bowel Disease: Complexity of Diagnosis, Treatment, and 3-Year Outcome

  • Allan Michael AndersenEmail author
  • Lee Elizabeth Wachtel
Chapter

Abstract

Catatonia has been resurrected as a diagnosis over the past 30 years and is now known to occur in a wide variety of psychiatric and medical scenarios. Increased emphasis has also been placed on recognizing this striking clinical entity in special populations including children and adolescents, and those with developmental disorders. Here we present a case of an adolescent female with inflammatory bowel disease who experienced a succession of provoking factors eventually culminating in catatonia. Her course was complicated by difficulty distinguishing catatonia from delirium, but she responded well once specific treatment was provided. Her case illustrates the importance of considering catatonia in medically complex patients.

Keywords

Catatonia Delirium ECT 

References

  1. 1.
    Penland HR, Weder N, Tampi RR. The catatonic dilemma expanded. Ann General Psychiatry. 2006;5(1):14.CrossRefGoogle Scholar
  2. 2.
    Fink M. Rediscovering catatonia: the biography of a treatable syndrome. Acta Psychiatr Scand. 2013;127(Supplement 441):1–50.CrossRefGoogle Scholar
  3. 3.
    Fink M, Taylor M. Catatonia. A clinician’s guide to diagnosis and treatment. Cambridge, UK: Cambridge University Press; 2003.CrossRefGoogle Scholar
  4. 4.
    Diagnostic and statistical manual of mental disorders (5th ed.): American Psychiatric Association; 2013.Google Scholar
  5. 5.
    Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatr. 2003;160(7):1233–41.CrossRefGoogle Scholar
  6. 6.
    Dhossche DM, Stoppelbein L, Rout UK. Etiopathogenesis of catatonia: generalizations and working hypotheses. J ECT. 2010;26(4):253–8.CrossRefGoogle Scholar
  7. 7.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders, DSM 5. 5th ed. Washington, DC: American Psychiatric Association; 2013.Google Scholar
  8. 8.
    Fink M, Shorter E, Taylor MA. Catatonia is not schizophrenia: Kraepelin’s error and the need to recognize catatonia as an independent syndrome in medical nomenclature. Schizophr Bull. 2009. Epub 2009/07/10. doi: sbp059 [pii] 9.1093/schbul/sbp059. PubMed PMID: 19586994.Google Scholar
  9. 9.
    Taylor M, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatr. 2003;160:1–9.CrossRefGoogle Scholar
  10. 10.
    Dhossche DM, Wachtel LE. Catatonia is hidden in plain sight among different pediatric disorders: a review article. Pediatr Neurol. 2010;43(5):307–15.CrossRefGoogle Scholar
  11. 11.
    Sienaert P, Dhossche DM, Vancampfort D, De Hert M, Gazdag G. A clinical review of the treatment of catatonia. Front Psych. 2014;5.Google Scholar
  12. 12.
    Wing L, Shah A. Catatonia in autistic spectrum disorders. Br J Psychiatry. 2000;176:357–62.CrossRefGoogle Scholar
  13. 13.
    Billstedt E, Gilberg C, Gilberg C. Autism after adolescence: population-based 13- to 22-year follow-up study of 120 individuals with autism diagnosed in childhood. J Autism Dev Disord. 2005;35:351–60.CrossRefGoogle Scholar
  14. 14.
    Ghaziuddin N, Marcotte K, Dhossche D. Retrospective chart review of catatonia in child and adolescent psychiatric patients. Acta Psychiatr Scand. 2012;125(1):33–8.CrossRefGoogle Scholar
  15. 15.
    Breen J, Hare D. The nature and prevalence of catatonic symptoms in young people with autism. J Intellect Disabil Res. 2017;61(6):580–93.CrossRefGoogle Scholar
  16. 16.
    Winarni T, Schneider A, Ghaziuddin N, Seritan A, Hagerman R. Psychosis and catatonia in fragile X: case report and literature review. Intractable Rare Dis Res. 2015;4(5):139–46.CrossRefGoogle Scholar
  17. 17.
    Faedda G, Wachtel L, AM H, Shprintzen R. Catatonia in an adolescent with velo-cardio-facial syndrome. Am J Med Genet A. 2015;167A(9):2150–3.CrossRefGoogle Scholar
  18. 18.
    Ghaziuddin N, Nassiri A, Miles JH. Catatonia in down syndrome; a treatable cause of regression. Neuropsychiatr Dis Treat. 2015;11:941–9.  https://doi.org/10.2147/NDT.S77307. PubMed PMID: 25897230; PMCID: PMC4396650.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Wachtel L, Dhossche D. Challenges of electroconvulsive therapy for catatonia in youth with intellectual disabilities: another tomato effect? J ECT. 2012;28(3):151–3. Epub 2012/08/24. 10.1097/YCT.0b013e31825692e2. PubMed PMID: 22914627.CrossRefGoogle Scholar
  20. 20.
    Doherty M, Garstin I, McClelland R, Rowlands B, Collins B. A steroid stupor in a surgical ward. Br J Psychiatry. 1991;158(1):125–7.CrossRefGoogle Scholar
  21. 21.
    Fink M, Shorter E. Does persisting fear sustain catatonia? Acta Psychiatr Scand. 2017;136(5):441–4.  https://doi.org/10.1111/acps.12796.CrossRefPubMedGoogle Scholar
  22. 22.
    Dhossche DM. Vagal intimations for catatonia and electroconvulsive therapy. J ECT. 2014;30(2):111–5.  https://doi.org/10.1097/YCT.0000000000000134.CrossRefPubMedGoogle Scholar
  23. 23.
    Wilson JE, Carlson R, Duggan MC, Pandharipande P, Girard TD, Wang L, Thompson JL, Chandrasekhar R, Francis A, Nicolson SE. Delirium and catatonia in critically Ill patients: the delirium and catatonia prospective cohort investigation. Crit Care Med. 2017;45:1837.CrossRefGoogle Scholar
  24. 24.
    Saddawi-Konefka D, Berg SM, Nejad SH, Bittner EA. Catatonia in the ICU: an important and underdiagnosed cause of altered mental status. A case series and review of the literature. Crit Care Med. 2014;42(3):e234–e41.CrossRefGoogle Scholar
  25. 25.
    Pandharipande P, Shintani A, Peterson J, Pun BT, Wilkinson GR, Dittus RS, Bernard GR, Ely EW. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiol J Am Soc Anesthesiologists. 2006;104(1):21–6.Google Scholar
  26. 26.
    Reti IM, Krishnan A, Podlisky A, Sharp A, Melinda W, Neufeld KJ, Hayat MJ. Predictors of electroconvulsive therapy postictal delirium. Psychosomatics. 2014;55(3):272–9.CrossRefGoogle Scholar
  27. 27.
    Barr J, Fraser GL, Puntillo K, Ely EW, Gélinas C, Dasta JF, Davidson JE, Devlin JW, Kress JP, Joffe AM. Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit. Crit Care Med. 2013;41(1):263–306.CrossRefGoogle Scholar
  28. 28.
    van den Berg KS, Marijnissen RM, van Waarde JA. Electroconvulsive therapy as a powerful treatment for delirium: a case report. J ECT. 2016;32(1):65–6.  https://doi.org/10.1097/YCT.0000000000000247.CrossRefPubMedGoogle Scholar
  29. 29.
    Ozdemir B, Celik C, Cinar A, Ozsahin A. Relief by electroconvulsive therapy for postsurgical delirium in malignant catatonia. J ECT. 2010;26(4):272–3.CrossRefGoogle Scholar
  30. 30.
    Dhossche DM, Wachtel LE, Goetz M, Sienaert P. Catatonia in psychiatric illnesses. In: The Medical Basis of Psychiatry: Springer; 2016. p. 517–35.Google Scholar
  31. 31.
    Llesuy JR, Coffey MJ, Jacobson KC, Cooper JJ. Suspected delirium predicts the thoroughness of catatonia evaluation. J Neuropsychiatry Clin Neurosci. 2016:appi. neuropsych. 15090230.Google Scholar
  32. 32.
    Consoli A, Raffin M, Laurent C, Bodeau N, Campion D, Amoura Z, Sedel F, An-Gourfinkel I, Bonnot O, Cohen D. Medical and developmental risk factors of catatonia in children and adolescents: a prospective case–control study. Schizophr Res. 2012;137(1):151–8.CrossRefGoogle Scholar
  33. 33.
    Carroll B, Anfinson T, Kennedy J, Yendrek R, Boutros M, Bilon A. Catatonic disorder due to general medical conditions. J Neuropsychiatry Clin Neurosci. 1993;6(2):122–33.Google Scholar
  34. 34.
    Leon T, Aguirre A, Pesce C, Sanhueza P, Toro P. Electroconvulsive therapy for catatonia in juvenile neuropsychiatric lupus. Lupus. 2014;23:1066. 0961203314533603.CrossRefGoogle Scholar
  35. 35.
    Sullivan BJ, Dickerman JD. Steroid-associated catatonia: report of a case. Pediatrics. 1979;63(4):677–9.PubMedGoogle Scholar
  36. 36.
    Dong TS, Henry JT, Stanley K, Pannain S. Catatonia induced by an ACTH-secreting neuroendocrine tumor: a case report. AACE Clin Case Rep. 2015;1(4):e245–e9.CrossRefGoogle Scholar
  37. 37.
    Northoff G. What catatonia can tell us about “top-down” modulation: a neuropsychiatric hypothesis. Behav Brain Sci. 2002;25:555–604.PubMedGoogle Scholar
  38. 38.
    Dhossche D, Bouman N. Catatonia in an adolescent with Prader-Willi syndrome. Ann Clin Psychiatry. 1997;4:247–53.CrossRefGoogle Scholar
  39. 39.
    Dhossche D, Song Y, Liu Y-M. Is there a connection between autism, Prader-Willi syndrome, catatonia, and GABA? Int Rev Neurobiol. 2005;71:189–216.CrossRefGoogle Scholar
  40. 40.
    Pincus JH, Tucker GJ. Behavioral neurology. Oxford, United Kingdom: Oxford University Press; 2002.Google Scholar
  41. 41.
    Dhossche D, Carroll B, Carroll T. Is there a common neuronal basis for autism and catatonia? Int Rev Neurobiol. 2006;72:151–64.CrossRefGoogle Scholar
  42. 42.
    Raffin M, Zugaj-Bensaou L, Bodeau N, Milhiet V, Laurent C, Cohen D, Consoli A. Treatment use in a prospective naturalistic cohort of children and adolescents with catatonia. Eur Child Adolesc Psychiatry. 2015;24(4):441–9.CrossRefGoogle Scholar
  43. 43.
    Fink M, Kellner CH, McCall WV. Optimizing ECT technique in treating catatonia. J ECT. 2016;32(3):149–50.  https://doi.org/10.1097/YCT.0000000000000345. PubMed PMID: 27428478.CrossRefPubMedGoogle Scholar
  44. 44.
    Bush G, Fink M, Petrides G, Dowling F, Francis A, Catatonia II. Treatment with lorazepam and electroconvulsive therapy. Acta Psychiatr Scand. 1996;93:137–43.CrossRefGoogle Scholar
  45. 45.
    Wachtel L, Hermida A, Dhossche D. Maintenance electroconvulsive therapy in autistic catatonia: a case series review. Prog Neuro-Psychopharmacol Biol Psychiatry. 2010;34(4):581–7. Epub 2010/03/20. doi: S0278-5846(10)00105-3 [pii] 10.1016/j.pnpbp.2010.03.012. PubMed PMID: 20298732.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Allan Michael Andersen
    • 1
    Email author
  • Lee Elizabeth Wachtel
    • 2
    • 3
  1. 1.Department of PsychiatryUniversity of Iowa Hospitals and ClinicsIowa CityUSA
  2. 2.Department of PsychiatryJohns Hopkins University School of MedicineBaltimoreUSA
  3. 3.Neurobehavioral Unit, Kennedy Krieger InstituteBaltimoreUSA

Personalised recommendations